|本期目录/Table of Contents|

[1]胡荐云,岐宏政,王云汉,等.血清降钙素原在上尿路结石腔内碎石术后尿源性脓毒血症中的早期诊断及预测价值[J].慢性病学杂志,2016,(08):910-912.
点击复制

血清降钙素原在上尿路结石腔内碎石术后尿源性脓毒血症中的早期诊断及预测价值(PDF)

《慢性病学杂志》[ISSN:1674-8166/CN:11-5900/R]

卷:
期数:
2016年08期
页码:
910-912
栏目:
专题报道
出版日期:
2016-09-27

文章信息/Info

Title:
-
作者:
胡荐云; 岐宏政; 王云汉; 易炜; 陈林; 胡海峰; 汪自立
成都大学附属医院泌尿外科，成都610081
Author(s):
-
关键词:
尿源性脓毒血症; 早期诊断; 血清降钙素原
Keywords:
-
分类号:
R696
DOI:
-
摘要:
目的评估血清降钙素原(PCT)在上尿路结石腔内碎石术后尿源性脓毒血症（Urosepsis） 中的早期诊断 价值。方法回顾性分析成都大学附属医院泌尿外科38 例上尿路结石腔内碎石术后发生严重尿路感染的患者临 床资料，分析其严重程度与PCT 结果之间的相关性。结果符合尿源性脓毒血症诊断的患者共23 例，其中7例 血清PCT<0.5 μg/L 的患者证实为尿源性脓毒血症1 例；3 例PCT 0.5~2 μg/L 的患者证实为尿源性脓毒血症1 例；11例PCT 2~10 μg/L 的患者证实为尿源性脓毒血症8例；16例PCT>10 μg/L 的患者证实为尿源性脓毒血 症13例。尿脓毒血症的血培养结果以格兰仕阴性菌为主。结论PCT 对于上尿路腔内碎石术后严重尿路感染的 诊断具有一定的临床意义，尤其对于PCT 值大于10 μg/L 的病例要高度怀疑尿源性脓毒血症，临床医师应该及 时、足量选用敏感抗生素。
Abstract:
-

参考文献/References:

[1] Türk C, Pet?íKA, Sarica K, et al. EAU Guidelines on Interventional Treatment for Urolithiasis [J]. Eur Urol, 2016,69(3):475-482.
[2] Dreger NM, Degener S, Ahmad- Nejad P, et al. Urosepsis- Etiology, Diagnosis and Treatment [J]. Dtsch Arztebl Int, 2015,112(49):837-847.
[3] Ludwig M, Kümmel C, Schroeder- Printzen I, et al. Evaluation of seminal plasma parametersin patients with chronic prostatitis or leukocytospermia [J]. Andrologia, 1998, 30(Suppl 1):41-47.
[4] Oberhofer D, Juras J, Pavici AM, et al. Comparison of C- reactive protein and procalcitonin as predictors of postoperative infectious complications after elective colorectal surgery[J]. Croat Med J, 2012,53(6):612-619.
[5] Jones AE, Fiechtl JF, Brown MD, et al. Procalcitonin test in the diagnosis of bacteremia: a meta- analysis [J]. Ann Emerg Med, 2007,50(1):34-41.
[6] Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [J]. JAMA, 2016,315(8):801-810.
[7] Al- Marhoon MS, Shareef O, Al- Habsi IS, et al. Extracorporeal Shock- wave Lithotripsy Success Rate and Complications: Initial Experience at Sultan Qaboos University Hospital [J]. Oman Med J, 2013,28(4):255-259.
[8] Cho SY. Current status of flexible ureteroscopy in urology [J]. Korean J Urol, 2015,56(10):680-688.
[9] Aikawa N, Fujishima S, Endo S, et al. Multicenter prospective study of procalcitonin as an indicator of sepsis [J]. J Infect Chemother, 2005,11(3):152-159.
[10] Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/ Society of Critical Care Medicine [J]. Chest, 1992, 101(6):1644-1655.
[11] Zheng J, Li Q, Fu W, et al. Procalcitonin as an early diagnostic and monitoring tool in urosepsis following percutaneous nephrolithotomy [J]. Urolithiasis, 2014,43(1):41-47.
[12] Hsueh PR, Hoban DJ, Carmeli Y, et al. Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia- Pacific region [J]. J Infect, 2011,63(2):114-123.
[13] Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock [J]. Crit Care Med, 2006,34(6):1589-1596.
[14] Tando?du Z, Bartoletti R, Cai T, et al. Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003- 2013 [J]. World J Urol, 2016,34(8): 1193-1200.
[15] qSingh S, Chatterji T, Sen M, et al. Serum procalcitonin levels in combination with HNMR spectroscopy: A rapid indicator for differentiation of urosepsis [J]. Clin Chim Acta, 2016,453:205-214.

备注/Memo

备注/Memo:
作者简介：胡荐云，硕士，住院医师，主要从事泌尿外科 临床工作 通信作者：胡荐云，E-mail: petercloud@163.com
更新日期/Last Update: 2016-09-27